logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Wen-Chi Chou

chang gung memorial hospital
H指数:32
被引数:4,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort

改良FOLFIRINOX在胰管腺癌中的最佳初始相对剂量强度：一项回顾性多中心队列研究

Journal of the Formosan Medical Association
IF2.5
2026-04-120
OAAI
I-Wei Ho; Chung-Pin Li; Shih-Hung Yang; Hsiu-Tzu Wang; Ching-Yeh Lin; Yung-Yeh Su; Ching-Liang Ho; Wen-Chi Chou; Tai-Jan Chiu; Yu-Hsuan Shih; Yin-Hsun Feng; Yueh-Shih Chang; Chao-Chien Hung; Chang-Fang Chiu; Li-Yuan Bai
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis

二线5-FU联合纳米脂质体伊立替康与FOLFOX/XELOX方案对比：在吉西他滨–白蛋白结合型紫杉醇治疗失败后的转移性胰腺癌中的倾向性评分匹配分析

ESMO Open
IF8.3
2025-11-070
OAAI
G. Trovato; D. Rossini; A. Guidolin; Y.-Y. Su; Y.-S. Shan; N.-J. Chiang; W.-C. Chou; L.-Y. Bai; C. Bagalà; M. Bensi; M. Niger; S. Marchesi; S.K. Garattini; A. Michelotti; A. Pretta; M. Scartozzi; C. Vivaldi; L. Bartalini; L. Procaccio; F. Bergamo; L. Antonuzzo; L.-T. Chen; L. Salvatore; G. Tortora
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南：胰腺癌患者的诊断、治疗和随访

ESMO Open
IF8.3
2025-10-090
OAAI
D. Tai; T. Conroy; J.J.X. Lee; C.E. Chee; C.-Y. Hao; I. Wijaya; S. Aggarwal; M. Ueno; H.-C. Jeung; N.M. Hashim; J. Tan Chun Bing; L.-T. Chen; K. Korphaisarn; S. Tanasanvimon; W.-C. Chou; E. Cargullo; N.F.A. Muin; M.A. Lee; A. Ohba; S. Bondarde; C.R.A. Lesmana; L. Wang; E.C. Smyth; T. Yoshino; G. Bonney; G. Pentheroudakis; J. Samol; A. Cervantes; E. Poon; M. Ducreux

研究方向

暂未获取到该数据
J
Jen‐Shi Chen
H 指数:44论文数:307被引数:2.4万
S
Siew Tzuh Tang
H 指数:38论文数:164被引数:4,718
F
Fur‐Hsing Wen
H 指数:21论文数:89被引数:1,249
W
Wen‐Cheng Chang
H 指数:26论文数:90被引数:2,007
Y
Yu‐Shin Hung
H 指数:25论文数:132被引数:1,673
K
Kun‐Yun Yeh
H 指数:28论文数:152被引数:2,256
C
Chia‐Hsun Hsieh
H 指数:19论文数:106被引数:1,080
T
Ta‐Sen Yeh
H 指数:45论文数:290被引数:6,990
C
Chia‐Hsun Hsieh
H 指数:32论文数:217被引数:3,481
C
Chia‐Yen Hung
H 指数:18论文数:64被引数:1,062